Skip to Content
Merck

Emprove® Program – Two Decades of Easing Risk Management

Twenty years of speeding up your journey. And still accelerating.

Maintaining compliance with current Good Manufacturing Practices (cGMPs) at any given time in your drug manufacturing process can be complex and challenging – especially in a global, dynamic environment. As a drug manufacturer, you need to compile a vast amount of information from your suppliers to ensure that the raw materials and components you purchase meet the technical, regulatory and supply needs for their designated application, use and function. This can be resource- and time-intensive, as well as expensive.

20 years ago, we launched the Emprove® Program to accelerate your risk assessments and help you maintain compliance. As your processes evolved, so did the Emprove® Program, anticipating challenges and keeping you ahead of the curve. With a comprehensive digital platform, the Emprove® Program speeds your drug development journey by offering convenient access to reliable information for a broad portfolio of high-quality products. This way, the Emprove® Program enables you to:

  • make more agile, risk-based decisions
  • maintain compliance and
  • demonstrate control – saving you time and money

There are three pillars of the Emprove® Program:



YOUR EMPROVE® PRODUCT PORTFOLIOS

We’ve continued to expand the scope of the Emprove® Program beyond Emprove® Chemicals. The Emprove® Program now covers more than 500 raw materials, 1,100 Filtration SKU’s and 450 Single-Use Components. Although some of these product portfolios do not contain the Emprove® Name in their brand name, they have been qualified into the Emprove® Program and their respective Emprove® Dossiers are included in the Emprove® Suite.

We leverage our biopharma and pharma regulatory intelligence and participation in industry associations to stay abreast of constantly evolving regulatory requirements, advancing industry guidance, and increasing customer expectations to determine which products would benefit from the Emprove® Program and what additional information would be of value to you. Then, we qualify those products into the Emprove® Program and add new content to our Emprove® Dossiers by proactively developing, obtaining, and compiling the information needed to address the specific requirements of the different product portfolios – giving you peace of mind.


YOUR TECHNICAL, REGULATORY AND SUPPLY INFORMATION

The Emprove® Qualified Product Portfolios are supported with reliable information in the Emprove® Dossiers, which have been compiled in line with the ICH Common Technical Document (CTD) Chapter 3 format. The Emprove® Dossiers are designed to support different steps in your raw material and component risk assessment continuum – streamlining your supplier selection, material qualification, process optimization, patient safety evaluation and more.

Quality Management Dossier (QMD)

Material Qualification Dossier (MQD)

Operational Excellence Dossiers (OED)

Contains information to support your risk assessment and to qualify us as a supplier according to ICH Q9 and EU 2015/C95/02 as they relate to (bio)pharmaceutical manufacturing

Contains information to support the risk assessment and qualification of your raw materials and components for use in (bio)pharmaceutical manufacturing

Contains elemental impurities, extractables information and more to help support your risk assessment and patient safety evaluation

FREE

FREE

PAID

API Evaluation

API Risk Assessment

Reduce Material Testing

Qualification, Optimization & Patient Safety Evaluation for Custom Products

API Information Packages

Elemental Impurities Information (for APIs)

Component Extractables Reports

Advanced Qualification Dossiers

Provides the necessary product quality information for the initial evaluation of the Active Pharmaceutical Ingredient with regards to all kinds of applications*

Provides the elemental impurities that may be present to assist in your risk assessment per ICH Q9

Contains information to reduce material testing and supports patient safety for components that are manufactured by other suppliers. 

Contains information to support the qualification of custom products for use in (bio)pharmaceutical manufacturing, as well as enables your patient safety evaluation for the commercialization phase

FREE

PAID

PAID

PAID

Choose from over 1,500 Emprove® Dossiers covering hundreds of raw and starting materials, filter products, single-use components, chromatography resins and cell culture media.

*Disclaimer: The API Information Package is not intended to be used as an official document for registration by the authorities. The registration procedure for active pharmaceutical ingredients in final drugs is strictly regulated. The CEP and DMF/ASMF procedures enable API manufacturers to protect their intellectual property. Access to CEPs and LoAs for US DMFs (and other DMFs) and ASMF applications can be provided on request to support drug applications using our Emprove® API.


The new Emprove<sup>®</sup> Suite

THE EMPROVE® SUITE: SPEED THROUGH COMPLEXITY WITH CONFIDENCE

Compliance with cGMPs is a continuum. Changes are constant. Audits and periodic reviews are necessary. That’s where the Emprove® Suite comes in: combining twenty years of experience of the Emprove® Program with all the benefits of an Information-as-a-Service digital platform.

Take a seat: The Emprove® Suite is here to accelerate your risk assessment journey and guides you to a future that brings confidence and convenience. As your co-pilot, it supports your need for easy access to reliable information – anywhere, anytime. A subscription helps you stay current: You can find, view and download Emprove® Dossiers, and “opt-in” for notifications to stay informed of document changes. You can also generate Emprove® Dossier download metrics, reports, and more.

A subscription to the Emprove® Suite empowers you to:

  • take advantage of everything the Emprove® Program has to offer
  • collaborate and share information globally
  • speed your way through the complexity of compliance with confidence

Related Product Resources



To subscribe today, simply complete and submit the reply form below after reading our Emprove® terms and conditions.

Sign In To Continue

To continue reading please sign in or create an account.

Don't Have An Account?